209 related articles for article (PubMed ID: 32454903)
1. Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders.
Bellan M; Dimagli A; Piccinino C; Giubertoni A; Ianniello A; Grimoldi F; Sguazzotti M; Nerviani A; Barini M; Carriero A; Smirne C; Burlone ME; Rigamonti C; Minisini R; Salmi L; Barbaglia MN; Castello LM; Sola D; Marino P; Avanzi GC; Pirisi M; Sainaghi PP
Dis Markers; 2020; 2020():2696173. PubMed ID: 32454903
[TBL] [Abstract][Full Text] [Related]
2. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus.
Liphaus BL; Lima L; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
Clin Rheumatol; 2020 Feb; 39(2):509-514. PubMed ID: 31655933
[TBL] [Abstract][Full Text] [Related]
3. Plasma sMer, sAxl and GAS6 levels correlate with disease activity and severity in lupus nephritis.
Gong S; Xu Z; Liu Y; Xing L; Ma J; Yu C; Liu X; Jia X; Xie R; Sui M
Eur J Clin Invest; 2019 Mar; 49(3):e13064. PubMed ID: 30588607
[TBL] [Abstract][Full Text] [Related]
4. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
5. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood.
Ekman C; Stenhoff J; Dahlbäck B
J Thromb Haemost; 2010 Apr; 8(4):838-44. PubMed ID: 20088931
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of TAM receptors and ligands in severe preeclampsia.
Peng S; Sun M; Sun X; Wang X; Jin T; Wang H; Han C; Meng T; Li C
Pregnancy Hypertens; 2018 Jul; 13():116-120. PubMed ID: 30177037
[TBL] [Abstract][Full Text] [Related]
7. Gas6/TAM system as potential biomarker for multiple sclerosis prognosis.
D'Onghia D; Colangelo D; Bellan M; Tonello S; Puricelli C; Virgilio E; Apostolo D; Minisini R; Ferreira LL; Sozzi L; Vincenzi F; Cantello R; Comi C; Pirisi M; Vecchio D; Sainaghi PP
Front Immunol; 2024; 15():1362960. PubMed ID: 38745659
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus.
Ekman C; Jönsen A; Sturfelt G; Bengtsson AA; Dahlbäck B
Rheumatology (Oxford); 2011 Jun; 50(6):1064-9. PubMed ID: 21278074
[TBL] [Abstract][Full Text] [Related]
9. Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis.
Smirne C; Rigamonti C; De Benedittis C; Sainaghi PP; Bellan M; Burlone ME; Castello LM; Avanzi GC
Dis Markers; 2019; 2019():2304931. PubMed ID: 31583026
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes.
Ekman C; Linder A; Akesson P; Dahlbäck B
Crit Care; 2010; 14(4):R158. PubMed ID: 20731857
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity.
Zizzo G; Guerrieri J; Dittman LM; Merrill JT; Cohen PL
Arthritis Res Ther; 2013; 15(6):R212. PubMed ID: 24325951
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction.
Caldentey G; García De Frutos P; Cristóbal H; Garabito M; Berruezo A; Bosch X; San Antonio R; Flores-Umanzor E; Perea RJ; De Caralt TM; Rodríguez J; Ortiz-Pérez JT
Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):708-716. PubMed ID: 29119801
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms.
Ekman C; Site DF; Gottsäter A; Lindblad B; Dahlbäck B
Clin Biochem; 2010 Jan; 43(1-2):110-4. PubMed ID: 19660445
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis.
Bellan M; Quaglia M; Nerviani A; Mauro D; Lewis M; Goegan F; Gibbin A; Pagani S; Salmi L; Molinari L; Castello LM; Avanzi GC; Cantaluppi V; Pirisi M; Sainaghi PP; Pitzalis C
Clin Exp Rheumatol; 2021; 39(1):132-138. PubMed ID: 32573415
[TBL] [Abstract][Full Text] [Related]
15. Increased concentrations of plasma growth arrest-specific 6 and its soluble tyrosine kinase receptor sAxl in Taiwanese women with pelvic inflammatory disease.
Chen SC; Ko JL; Yang SF; Tsai MY; Tsai HT; Tang CH; Wang PH
Clin Chim Acta; 2013 Nov; 426():85-90. PubMed ID: 24045047
[TBL] [Abstract][Full Text] [Related]
16. Serum GAS6, sAXL, IL-10, NO, and BCL-2 levels are decreased in patients with Behçet's disease.
Baskol G; Yetkin MÖ; Sevim DG; Guclu K; Arda H; Saracoglu H; Gahramanov K; Evereklioglu C
Indian J Ophthalmol; 2024 May; 72(Suppl 3):S468-S472. PubMed ID: 38648454
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia.
Ekman C; Gottsäter A; Lindblad B; Dahlbäck B
Clin Biochem; 2010 Jul; 43(10-11):873-6. PubMed ID: 20417630
[TBL] [Abstract][Full Text] [Related]
18. Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors.
Apostolo D; D'Onghia D; Tonello S; Minisini R; Baricich A; Gramaglia C; Patrucco F; Zeppegno P; Acquaviva A; Balbo PE; Castello LM; Cappellano G; Chiocchetti A; Gerevini C; Giordano M; Laaguid F; Manfredi M; Raineri D; Rigamonti C; Rolla R; Romano V; Confalonieri M; Savoia P; Zavattaro E; Pirisi M; Ruaro B; Sainaghi PP; Bellan M;
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047229
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of sAxl are associated with severe preeclampsia.
Liu X; Gong Y; Jia J; Bai Y; Gui S; Wang T; Zhou R
Clin Biochem; 2014 Feb; 47(3):173-6. PubMed ID: 24239956
[TBL] [Abstract][Full Text] [Related]
20. Possible Association of Elevated Plasma Levels of Growth Arrest-Specific Protein 6 and the Soluble Form of Tyrosine Kinase Receptor Axl with Low Hepatitis C Viral Load in Patients with Type 2 Diabetes Mellitus.
Bassyouni RH; Gomaa AA; Hassan EA; Ali ESG; Khalil MAF; Mashahit MA; Gaber SN
Viral Immunol; 2020 Mar; 33(2):105-111. PubMed ID: 31905327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
